Kelly Aubertin
- Biophysics top 1%
- Spectroscopy Techniques in Biomedical and Chemical Research 8
- Analytical Chemistry top 2%
- Spectroscopy and Chemometric Analyses 8
- Cancer Research top 10%
- Biomedical Engineering top 10%
- Nanoplatforms for cancer theranostics 5
-
- Nanoparticle-Based Drug Delivery 2
-
- Extracellular vesicles in disease 8
- RNA Interference and Gene Delivery 3
-
- Gold and Silver Nanoparticles Synthesis and Applications 2
-
- Bee Products Chemical Analysis 2
Kelly Aubertin
20 papers receiving 844 citations
Peers
Comparison fields: 5 of 99
- Biophysics 274
- Analytical Chemistry 172
- Cancer Research 184
- Biomedical Engineering 306
- Biomaterials 83
Countries citing papers authored by Kelly Aubertin
This map shows the geographic impact of Kelly Aubertin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kelly Aubertin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kelly Aubertin more than expected).
Fields of papers citing papers by Kelly Aubertin
This network shows the impact of papers produced by Kelly Aubertin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kelly Aubertin. The network helps show where Kelly Aubertin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Kelly Aubertin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 1 | |
| 5 | 2022 | 9 | |
| 6 | 2021 | 2 | |
| 7 | 2021 | 65 | |
| 8 | 2018 | 36 | |
| 9 | 2018 | 49 | |
| 10 | 2017 | 78 | |
| 11 | 2017 | 3 | |
| 12 | 2017 | 18 | |
| 13 | 2017 | 2 | |
| 14 | 2016 | 101 | |
| 15 | 2016 | 105 | |
| 16 | 2016 | 12 | |
| 17 | 2015 | 130 | |
| 18 | 2014 | 87 | |
| 19 | 2013 | 6 | |
| 20 | 2012 | 19 |
About Kelly Aubertin
Kelly Aubertin is a scholar working on Biophysics, Analytical Chemistry and Biomedical Engineering, having authored 22 papers that have together received 860 indexed citations. Recurring topics across this work include Extracellular vesicles in disease (8 papers), Spectroscopy Techniques in Biomedical and Chemical Research (8 papers), Spectroscopy and Chemometric Analyses (8 papers), Nanoplatforms for cancer theranostics (5 papers), RNA Interference and Gene Delivery (3 papers), Nanoparticle-Based Drug Delivery (2 papers), Gold and Silver Nanoparticles Synthesis and Applications (2 papers) and Bee Products Chemical Analysis (2 papers). The work is most often cited by research in Biophysics (274 citations), Analytical Chemistry (172 citations) and Cancer Research (184 citations). Kelly Aubertin has collaborated with scholars based in France, Canada and United States. Frequent co-authors include Claire Wilhelm, Amanda Silva, Florence Gazeau, Nathalie Luciani, Frédéric Leblond, Joannie Desroches, Michael Jermyn, Dominique Trudel, Stéphanie Bonneau and Kevin Petrecca. Their work appears in journals such as ACS Nano, Analytical and Bioanalytical Chemistry, Scientific Reports, Medical Physics and Nanoscale.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.